NCT03621072 Bioequivalence (BE) Study Comparing Fluconazole 150mg Capsule Manufactured in China and in France Status COMPLETED Phase PHASE1
NCT03620643 Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours Status COMPLETED Phase PHASE2
NCT03617666 Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03616158 Investigate the Development and Progression of Lung Disease in Rheumatoid Arthritis Over Time Status UNKNOWN Phase N/A
NCT03615651 Probiotic Effects on the Microbe-brain-gut Interaction and Brain Activity During Stress Tasks in Healthy Subjects Status COMPLETED Phase NA
NCT03612557 A Study of Benzathine Benzylpenicillin Intramuscular Injection in Japanese Healthy Subjects Status COMPLETED Phase PHASE1
NCT03609047 Adjuvant Palbociclib in Elderly Patients With Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03608241 A STUDY TO ESTIMATE THE EFFECT OF PF-06651600 ON THE PHARMACOKINETICS (PK) OF ORAL CONTRACEPTIVE (OC) Status COMPLETED Phase PHASE1
NCT03606135 Etiology and Incidence Assessment of Radiographically-confirmed Community Acquired Pneumonia (CAP) Status COMPLETED Phase N/A
NCT03603847 Prospective Study of the Prognostic Value of New Markers in Adults With ALK-positive Large Anaplastic Lymphoma Status COMPLETED Phase N/A
NCT03599063 Singe Dose, First in Human Study of PF- 06946860 in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT03597217 A Single and Multiple Dose Study of PF-05221304 in Healthy Japanese Adults Status COMPLETED Phase PHASE1
NCT03593707 Drug-Drug Interaction Study to Evaluate the Effect of PF-06865571 on Metformin Pharmacokinetics Status COMPLETED Phase PHASE1
NCT03592199 Biomarker Study of Pts With Metastatic ccRCC Undergoing Sequential Therapy With 1st Line Sunitinib and 2nd Line Axitinib Status UNKNOWN Phase PHASE2
NCT03587116 A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%) Status COMPLETED Phase PHASE3
NCT03580044 Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria Status TERMINATED Phase PHASE3
NCT03580005 A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD. Status WITHDRAWN Phase PHASE4